Atherectomy Devices Market Report Scope & Overview:

The Atherectomy Devices Market was valued at USD 0.94 Billion in 2025 and is expected to reach USD 1.90 Billion by 2035, growing at a CAGR of 7.29% from 2026 to 2035.

The Atherectomy Devices Market continues to grow owing to the rising incidences of peripheral arterial diseases and coronary artery diseases among an elderly and diabetic population, thus leading to a continuous demand for minimally invasive techniques that can remove plaques. Atherectomy is gaining more preference than bypass surgery owing to its minimally invasive technique, quicker recovery, and better procedural results. There have been technological innovations that are improving the precision and efficacy of plaque removal by means of atherectomy devices, while next-generation devices incorporating AI-driven imaging and analytics systems are revolutionizing the treatment of complex and heavily calcified lesions.

Abbott led the atherectomy devices market with over twenty-five percent market share in 2025, with the top five companies in the industry, including Abbott, Becton Dickinson, Boston Scientific, Medtronic, and Philips, collectively holding eighty-two percent of total market share, reflecting a highly concentrated competitive landscape among established medical device leaders.

Market Size and Forecast

• Market Size in 2026E: USD 1.01 Billion
• Market Size by 2035: USD 1.90 Billion
• CAGR: 7.29% from 2026 to 2035
• Fastest Growing Region: Asia Pacific
• Largest Region: North America

To Get more information On Atherectomy Devices Market - Request Free Sample Report

Atherectomy Devices Market Trends

• Next-generation devices with AI-driven imaging and real-time analytics continue revolutionizing plaque removal precision.
• Increasing preference for minimally invasive procedures continues driving atherectomy adoption over traditional bypass surgery.
• Technological advancements, including miniaturization and improved imaging, continue enhancing device precision and efficacy.
• Rising target patient populations, driven by aging and diabetic demographics, continue expanding the addressable market.
• Geographic expansion into emerging markets continues opening new growth avenues for device manufacturers.

The United States Atherectomy Devices Market Outlook

The United States Atherectomy Devices Market was valued at USD 0.336 Billion in 2025 and is expected to reach USD 0.693 Billion by 2035, growing at a CAGR of 7.50% from 2026 to 2035.

North America Atherectomy Devices Market is dominated by the US, fueled by the superior healthcare system and extensive use of interventional cardiology procedures in the major vascular treatment facilities in the country. There is a huge prevalence of coronary artery disease and peripheral artery disease in the country, which fuels the need for technology to remove plaque, which is why atherectomy is being increasingly used in hospitals and specialized medical clinics.

Cardiovascular Systems, headquartered in St. Paul, Minnesota, continued advancing its orbital atherectomy technology in 2025, reinforcing its position within the American peripheral and coronary intervention device market as physicians increasingly favor its spinning crown mechanism for treating heavily calcified lesions.

Atherectomy Devices Market Segmentation Analysis

• By Product Type, the directional atherectomy devices segment held approximately 41.78% share in atherectomy devices market in 2025, while the orbital atherectomy devices segment is the fastest growing.
• By Application, the peripheral vascular disease segment held approximately 57.45% share in atherectomy devices market in 2025, while the neurovascular procedures segment is the fastest growing, with a CAGR of approximately 7.86%.
• By Device Type, the drug-coated balloons segment held the largest share in atherectomy devices market in 2025, while the rotational atherectomy devices segment is the fastest growing.
• By End User, the hospitals surgical centers segment held approximately 63.05% share in atherectomy devices market in 2025, while the ambulatory surgical centers segment is the fastest growing, with a CAGR of approximately 7.93%.

By Product Type, directional atherectomy devices dominated the atherectomy devices market, orbital atherectomy devices grew fastest

The directional atherectomy devices segment dominated the product type category in 2025, holding approximately 41.78% of total revenue, favored for its established effectiveness in removing plaque from larger arteries, particularly in the lower extremities. That established clinical track record keeps directional devices firmly at the top of the broader product type segmentation across the majority of peripheral vascular interventions worldwide.

The orbital atherectomy devices segment is projected to grow at a strong CAGR during the forecast period, driven by its ability to provide consistent and controlled plaque modification, particularly in heavily calcified lesions. These devices utilize a spinning crown mechanism to safely sand away plaque while preserving arterial wall integrity, making them highly suitable for both peripheral and coronary interventions, continuing to push this product category's growth rate ahead of the broader product type segmentation.

By Application, peripheral vascular disease dominated the atherectomy devices market, neurovascular procedures grew fastest

The peripheral vascular disease segment held the largest application share in 2025, at approximately 57.45%, reflecting the rising prevalence of peripheral artery disease that continues driving demand for minimally invasive plaque removal across large patient populations. That sustained peripheral vascular disease burden keeps this application category firmly at the center of overall atherectomy devices demand across nearly every major regional market worldwide.

The neurovascular procedures segment is projected to grow at the fastest CAGR of approximately 7.86% during the forecast period, as atherectomy techniques continue expanding into cerebrovascular applications where precise plaque removal can reduce stroke risk. Rising clinical adoption of atherectomy for neurovascular indications continues pushing this application category's growth rate ahead of the broader application segmentation.

By Device Type, drug-coated balloons dominated the atherectomy devices market, rotational atherectomy devices grew fastest

The drug-coated balloons segment held the largest device type share in 2025, favored as an increasingly common adjunctive treatment that continues pairing effectively with atherectomy procedures to reduce restenosis rates following plaque removal. That complementary treatment role keeps drug-coated balloons firmly at the top of the broader device type segmentation across the majority of comprehensive vascular intervention protocols worldwide.

The rotational atherectomy devices segment is projected to grow at the fastest CAGR during the forecast period, as this mechanical approach continues proving effective for treating heavily calcified lesions that other atherectomy modalities may struggle to address efficiently. Rising demand for versatile plaque modification technology continues pushing this device type category's growth rate ahead of the broader device type segmentation.

By End User, hospitals surgical centers dominated the atherectomy devices market, ambulatory surgical centers grew fastest

The hospitals surgical centers segment held the largest end-user share in 2025, at approximately 63.05%, anchored by comprehensive procedural infrastructure and specialist availability that continues supporting complex atherectomy interventions. That established procedural infrastructure keeps hospitals and surgical centers firmly at the top of the broader end-user segmentation across nearly every major atherectomy devices deployment worldwide.

The ambulatory surgical centers segment is projected to grow at the fastest CAGR of approximately 7.93% during the forecast period, as the preference for outpatient care continues shifting appropriate atherectomy procedures away from traditional hospital settings toward lower-cost, higher-throughput ambulatory facilities. Rising patient and payer preference for outpatient procedural settings continues pushing this end-user category's growth rate ahead of the broader end-user segmentation.

Regional Analysis

North America Atherectomy Devices Market Insights

North America held the largest share of the global atherectomy devices market in 2025, at approximately 42.00%, driven by advanced healthcare infrastructure and high adoption of interventional cardiology procedures across the region. The region faces a significant burden of coronary artery disease and peripheral artery disease, driving sustained demand for plaque removal technologies throughout the year.

North America was the highest-grossing region in the market, accounting for 85.30% of all regional revenues, due to the presence of the biggest players in atherectomy devices and interventional cardiology. Canada was a smaller yet growing part of North American regional revenue due to growing vascular treatments within its borders.

Get Customized Report as per Your Business Requirement - Enquiry Now

Europe Atherectomy Devices Market Insights

Europe held a substantial share of the global atherectomy devices market in 2025, supported by well-established national health insurance coverage and strong interventional cardiology infrastructure across the continent. Germany accounted for roughly 27.40% of regional revenue, supported by its concentration of vascular device manufacturers and advanced hospital infrastructure.

France, the United Kingdom, and Italy followed a broadly similar trajectory, as continued investment in interventional cardiology capability extended atherectomy devices adoption across the continent's largest healthcare markets. Continued emphasis on minimally invasive treatment options is expected to keep supporting steady European demand through the remainder of the forecast period.

Asia Pacific Atherectomy Devices Market Insights

Asia Pacific was the fastest-growing region in the global atherectomy devices market, driven by rising cardiovascular and peripheral artery disease prevalence, expanding healthcare infrastructure investment, and growing interventional cardiology capability across the region's largest economies. Rising awareness of minimally invasive treatment options continued driving regional demand at a pace considerably faster than more mature Western markets.

Japan accounted for roughly 35.60% of regional revenue, supported by its advanced healthcare infrastructure and early adoption of sophisticated vascular intervention technology. China and South Korea contributed significant additional regional demand through their own expanding interventional cardiology capacity, reinforcing Asia Pacific's position as the clear growth leader in this market.

MEA & Latin America Atherectomy Devices Market Insights

Atherectomy Devices Market in the Middle East & Africa registered a healthy growth rate in 2025 due to increased investments in healthcare infrastructure, along with the favorable stance of governments on advanced cardiovascular care, especially among the Gulf countries. Revenue contribution of the UAE in this region was around 26.30%, facilitated by the healthcare improvement programs in the country.

Latin America expanded at a comparable pace, led by Brazil at roughly 37.50% of regional revenue, where growing cardiovascular disease treatment investment continued to support category growth. Mexico and Argentina followed a similar trajectory as regional interventional cardiology capacity expanded further through the remainder of the forecast period.

Growth Drivers: Rising disease prevalence and minimally invasive procedure preference

Rising prevalence of peripheral artery disease and coronary artery disease, especially among aging and diabetic populations, continues to be the central force behind atherectomy devices market growth. Increasing preference for minimally invasive procedures continues driving atherectomy adoption over traditional surgical methods, as these procedures offer reduced recovery time and improved procedural outcomes relative to bypass surgery.

Increasing patient base coupled with technological innovation in terms of size reduction and enhanced imaging technology of atherectomy devices is contributing to increased effectiveness in removing plaque. The latest atherectomy devices with AI-powered imaging technology have been providing strong support for the increasing structural demand in almost all areas of atherectomy devices applications.

Restraints: High device costs and steep operator learning curve

The high cost of devices and associated procedures continues restricting adoption among smaller hospitals and surgical centers working with constrained capital budgets. That cost barrier continues concentrating the most advanced atherectomy technology within larger, well-capitalized healthcare systems capable of absorbing both equipment and procedural costs.

The steep learning curve and operator dependency associated with atherectomy procedures continues requiring substantial physician training investment before these devices can be deployed safely and effectively. That specialized training requirement continues limiting the pace at which broader interventional cardiology adoption can expand beyond already-experienced practitioners.

Opportunities: Emerging market expansion and AI-enhanced imaging integration

Geographic expansion into emerging markets presents substantial opportunity for device manufacturers positioned to serve regions with growing interventional cardiology capability but historically limited access to advanced atherectomy technology. Manufacturers capable of delivering cost-effective, training-supported device programs stand to capture a growing share of demand as these markets continue developing.

Continued integration of AI-driven imaging and real-time analytics presents a further significant growth avenue, as next-generation devices continue revolutionizing physician confidence in treating the most challenging, heavily calcified lesions. Manufacturers capable of delivering genuinely intelligent, precision-enhanced atherectomy platforms stand to capture meaningful new revenue streams through 2035.

Recent Developments:

• 2025: Boston Scientific continued expanding its peripheral intervention device portfolio, strengthening its position serving interventional cardiologists and vascular surgeons requiring advanced atherectomy and adjunctive treatment technology.
• 2025: Medtronic continued advancing its peripheral vascular device technology, targeting hospitals and ambulatory surgical centers seeking integrated atherectomy and drug-coated balloon treatment protocols.
• 2023: Abbott completed its acquisition of Cardiovascular Systems, Inc. (CSI), expanding its portfolio of atherectomy devices and strengthening its position in the treatment of peripheral and coronary artery disease.

Atherectomy Devices Market key players are:

• Abbott Laboratories
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Medtronic plc
• Koninklijke Philips N.V.
• AngioDynamics, Inc.
• Avinger, Inc.
• Ra Medical Systems, Inc.
• REX Medical
• Cardio Flow, Inc.
• Terumo Corporation
• Straub Medical AG
• Cardiovascular Systems, Inc.
• Cardinal Health, Inc.
• Merit Medical Systems, Inc.
• BIOTRONIK SE & Co. KG
• Cook Medical Incorporated
• Endologix LLC
• Spectranetics
• W. L. Gore & Associates, Inc.

Atherectomy Devices Market Report Scope :